688319 歐林生物
按盤價 
21.610 +3.440 (+18.932%) | 2025/03 - 三個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.767 | 2.254 | 1.952 | 3.079 | 17.675 |
| 總資產報酬率 ROA (%) | -0.395 | 1.214 | 1.136 | 1.975 | 11.652 |
| 投入資產回報率 ROIC (%) | -0.545 | 1.693 | 1.602 | 2.763 | 16.560 | 邊際利潤分析 |
| 銷售毛利率 (%) | 93.430 | 94.446 | 93.550 | 92.865 | 93.927 |
| 營業利潤率 (%) | -8.050 | 3.619 | 0.625 | 7.601 | 20.852 |
| 息稅前利潤/營業總收入 (%) | -3.994 | 5.488 | 4.091 | 8.212 | 21.991 |
| 淨利潤/營業總收入 (%) | -8.048 | 2.670 | 2.306 | 4.854 | 22.162 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 228.244 | 84.567 | 33.731 | 67.609 | 94.906 |
| 價值變動淨收益/利潤總額(%) | -1.003 | 3.836 | 6.671 | 8.478 | 3.512 |
| 營業外收支淨額/利潤總額(%) | -0.024 | 4.454 | 80.159 | 4.656 | 5.231 | 償債能力分析 |
| 流動比率 (X) | 1.606 | 1.525 | 1.955 | 1.782 | 2.561 |
| 速動比率 (X) | 1.448 | 1.381 | 1.804 | 1.632 | 2.343 |
| 資產負債率 (%) | 47.669 | 48.341 | 42.282 | 39.694 | 30.302 |
| 帶息債務/全部投入資本 (%) | 27.297 | 26.115 | 18.658 | 11.303 | 2.665 |
| 股東權益/帶息債務 (%) | 258.236 | 274.486 | 422.883 | 757.413 | 3,545.245 |
| 股東權益/負債合計 (%) | 108.733 | 105.854 | 134.475 | 150.186 | 230.013 |
| 利息保障倍數 (X) | -0.985 | 3.227 | 4.335 | 34.304 | -1,787.579 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 575.084 | 323.304 | 356.438 | 272.293 | 194.981 |
| 存貨周轉天數 (天) | 1,337.349 | 868.416 | 847.387 | 705.108 | 733.200 |
| 備註： | 即時報價更新時間為 18/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
